Artículos del autor

solaci

Day 2

EXAMINE: The alogliptin is safe for treating type 2 diabetes in patients with a recent history of acute coronary syndrome.

Type 2 diabetes is associated both microvascular and macrovascular disease. Adequate glycemic control can reduce the risk...

solaci - 24 June, 2015

Day 2

COMPARE: Losartan shows promising results in patients with Marfan syndrome

Patients with Marfan syndrome (connective tissue disorder) are more susceptible to aortic dilation and consequently dissection and...

solaci - 24 June, 2015

Day 2

ASSURE: Inducing Apo A-1 agent failed to reduce atherosclerotic plaque

Induction apoA-1 synthesis is a new therapeutic approach for the functional HDL particles generation. The RVX-208 induces...

solaci - 24 June, 2015

Day 2

SAVOR-TIMI 53: Saxagliptin showed no cardiovascular benefit

The cardiovascular safety and efficacy of some hypoglycemic including saxagliptin (Onglyza), an inhibitor of dipeptidyl peptidase 4...

solaci - 24 June, 2015

SOLACI

2nd-generation drug-eluting stents, results for “real” patients at two years

Original title: Clinical Outcome Following Stringent Discontinuation of Dual Anti-Platelet Therapy After 12 Months in Real-World Patients Treated...

solaci - 2 June, 2015

Institutional News

SOLACI lamenta el fallecimiento de la Dra. Liliana Grinfeld

La Sociedad Latinoamericana de Cardiología Intervencionista (SOLACI) lamenta comunicar que en el día de la fecha ha...

solaci - 2 June, 2015

Institutional News

SOLACI -SIAC collaboration agreement

As the President of the Interamerican Society of Cardiology, (SIAC), I am honored to sign this important...

solaci - 2 June, 2015

Institutional News

Cooperation Agreement SOLACI-CRF/TCT

On April 12, a five year cooperation agreement was signed in Sao Paulo (Brazil) between SOLACI and...

solaci - 2 June, 2015

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Dr. Andrés Rodríguez - 19 June, 2026 0

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide. Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Dr. Omar Tupayachi - 17 June, 2026 0

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Dr. Juan Manuel Pérez - 16 June, 2026 0

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Noticias Institucionales

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

solaci - 17 June, 2026 0

Share your experience. Learn from experts. Grow as an interventional cardiologist. A new edition of the Fellow’s Corner is here, an academic exchange space designed...

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

solaci - 15 June, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

solaci - 10 June, 2026 0

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.